mRNA Vaccine Technology Beyond COVID-19

Area of Science:

• Vaccinology
• Molecular Biology
• Immunotherapy

Background:

• Messenger RNA (mRNA) vaccine technology has emerged as a significant therapeutic approach since early 2020, particularly following the COVID-19 pandemic.
• This platform offers potential applications beyond infectious diseases, extending to other medical areas.

Purpose of the Study:

• To review the current status of mRNA vaccine technology.
• To explore the application of mRNA vaccines against diseases other than COVID-19.

Main Methods:

• Searched clinicaltrial.gov and company websites for ongoing clinical trials.
• Accessed NCBI databases for recent articles, clinical trial reports, innovative mRNA vaccine designs, and reviews.

Main Results:

• Significant progress in mRNA vaccine design and technology has been observed.
• Hundreds of ongoing clinical trials target various cancers, infectious diseases, and genetic disorders, indicating technological advancement.
• mRNA vaccines show potential therapeutic advantages over traditional platforms, especially for cancer treatment.

Conclusions:

• Many ongoing clinical trials report positive outcomes, with several reaching Phase III.
• Some trials have been terminated or withdrawn, necessitating further investigation.
• Continued research and critical evaluation are essential to understand the immunological benefits and long-term effects of mRNA innovations.